Literature DB >> 21437010

Aminoglycoside block of P2X2 receptors heterologously expressed in Xenopus laevis oocytes.

Eva-Verena Bongartz, Jürgen Rettinger, Ralf Hausmann.   

Abstract

Aminoglycosides are polycationic antibiotics that have been shown to block a variety of cation channels. The inhibitory effect of externally applied aminoglycosides on P2X2 receptor currents was examined after heterologous expression in Xenopus laevis oocytes using the two-electrode voltage-clamp technique. All of the aminoglycosides tested inhibited the ATP-evoked responses with potencies ranging from 71 μM to 2 mM (IC(50) values). The ranked order of potency was streptomycin > gentamicin > neomycin > paromomycin > kanamycin. The inhibition of P2X receptor currents was independent of the ATP concentration used for the activation, which is compatible with a noncompetitive mechanism. The inhibition was voltage-dependent and was reduced at more positive membrane potentials. To examine whether the current block was dependent on the receptor conformation, the aminoglycoside effect on a non-desensitizing P2X2-X1 receptor chimera was analyzed. The results from these measurements suggest that inhibition is caused by an open pore block that locks the P2X receptor chimera in an open nonconducting state from which the agonist dissociation is slow. We also demonstrate that the P2X2-X1 chimera can serve as a tool to directly test whether an antagonist acts competitively or not.

Entities:  

Keywords:  Aminoglycoside antibiotics; Open pore block; P2X; Xenopus oocytes

Year:  2010        PMID: 21437010      PMCID: PMC3033503          DOI: 10.1007/s11302-010-9204-9

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  43 in total

Review 1.  Endogenous ion channels in oocytes of xenopus laevis: recent developments.

Authors:  W M Weber
Journal:  J Membr Biol       Date:  1999-07-01       Impact factor: 1.843

2.  Localization of cholinergic and purinergic receptors on outer hair cells isolated from the guinea-pig cochlea.

Authors:  G D Housley; D Greenwood; J F Ashmore
Journal:  Proc Biol Sci       Date:  1992-09-22       Impact factor: 5.349

3.  Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.

Authors:  Jürgen Rettinger; Kirsten Braun; Henrike Hochmann; Matthias U Kassack; Heiko Ullmann; Peter Nickel; Günther Schmalzing; Günter Lambrecht
Journal:  Neuropharmacology       Date:  2005-03       Impact factor: 5.250

4.  Antibiotics cause changes in the desensitization of ACh receptors expressed in Xenopus oocytes.

Authors:  T Okamoto; K Sumikawa
Journal:  Brain Res Mol Brain Res       Date:  1991-01

5.  Stimulatory and inhibitory properties of aminoglycoside antibiotics at N-methyl-D-aspartate receptors.

Authors:  T Masuko; T Kuno; K Kashiwagi; T Kusama; K Williams; K Igarashi
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

6.  P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.

Authors:  A Nicke; H G Bäumert; J Rettinger; A Eichele; G Lambrecht; E Mutschler; G Schmalzing
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

7.  The nature of neuromuscular block produced by neomycin and gentamicin.

Authors:  O Vital Brazil; J Prado-Franceschi
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-05

Review 8.  Ototoxicity: therapeutic opportunities.

Authors:  Leonard P Rybak; Craig A Whitworth
Journal:  Drug Discov Today       Date:  2005-10-01       Impact factor: 7.851

9.  Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH.

Authors:  Jayasankar Jasti; Hiroyasu Furukawa; Eric B Gonzales; Eric Gouaux
Journal:  Nature       Date:  2007-09-20       Impact factor: 49.962

10.  Subconductance block of single mechanosensitive ion channels in skeletal muscle fibers by aminoglycoside antibiotics.

Authors:  B D Winegar; C M Haws; J B Lansman
Journal:  J Gen Physiol       Date:  1996-03       Impact factor: 4.086

View more
  7 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

2.  Allosteric nature of P2X receptor activation probed by photoaffinity labelling.

Authors:  Y Bhargava; J Rettinger; A Mourot
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

3.  Conformational flexibility of the agonist binding jaw of the human P2X3 receptor is a prerequisite for channel opening.

Authors:  M Kowalski; R Hausmann; A Dopychai; M Grohmann; H Franke; K Nieber; G Schmalzing; P Illes; T Riedel
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Kanamycin Damages Early Postnatal, but Not Adult Spiral Ganglion Neurons.

Authors:  Kelei Gao; Dalian Ding; Hong Sun; Jerome Roth; Richard Salvi
Journal:  Neurotox Res       Date:  2017-06-27       Impact factor: 3.911

Review 5.  Identifying targets to prevent aminoglycoside ototoxicity.

Authors:  Jinkyung Kim; Sriram Hemachandran; Alan G Cheng; Anthony J Ricci
Journal:  Mol Cell Neurosci       Date:  2022-03-24       Impact factor: 4.626

6.  Systemic Fluorescent Gentamicin Enters Neonatal Mouse Hair Cells Predominantly Through Sensory Mechanoelectrical Transduction Channels.

Authors:  Ayane Makabe; Yoshiyuki Kawashima; Yuriko Sakamaki; Ayako Maruyama; Taro Fujikawa; Taku Ito; Kiyoto Kurima; Andrew J Griffith; Takeshi Tsutsumi
Journal:  J Assoc Res Otolaryngol       Date:  2020-03-09

7.  Extracellular gentamicin reduces the activity of connexin hemichannels and interferes with purinergic Ca(2+) signaling in HeLa cells.

Authors:  Vania A Figueroa; Mauricio A Retamal; Luis A Cea; José D Salas; Aníbal A Vargas; Christian A Verdugo; Oscar Jara; Agustín D Martínez; Juan C Sáez
Journal:  Front Cell Neurosci       Date:  2014-09-04       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.